Cytosorbents | SCHEDULE 13G/A: Others
Cytosorbents | SCHEDULE 13G: Others
Cytosorbents | 4: Statement of changes in beneficial ownership of securities-Director BATOR MICHAEL G.
Cytosorbents | 4: Statement of changes in beneficial ownership of securities-Officer Capponi Vincent
Cytosorbents | 4: Statement of changes in beneficial ownership of securities-Officer Deliargyris Efthymios
Cytosorbents | 4: Statement of changes in beneficial ownership of securities-Director Sobel Alan D.
Cytosorbents | 4: Statement of changes in beneficial ownership of securities-Officer Chan Phillip P.
Cytosorbents | 4: Statement of changes in beneficial ownership of securities-Officer MARIANI PETER J
Cytosorbents | SCHEDULE 13G: Others
Cytosorbents | 8-K: Current report
Cytosorbents | SCHEDULE 13G: Others
Cytosorbents | 8-K: Current report
Cytosorbents | 8-K: Current report
Cytosorbents | 8-K: Current report
Cytosorbents | 4: Statement of changes in beneficial ownership of securities-Officer MARIANI PETER J
Cytosorbents | 4: Statement of changes in beneficial ownership of securities-Officer MARIANI PETER J
Cytosorbents | FWP: Filing under Securities Act Rules 163/433 of free writing prospectuses
Cytosorbents | 424B5: Prospectus
Cytosorbents | 8-K: Current report
Cytosorbents | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Granahan Investment Management LLC(3.85%)